These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17029149)

  • 41. ACTG 384 at Barcelona: the bottom line.
    James JS
    AIDS Treat News; 2002 Aug; (382):4. PubMed ID: 12236205
    [No Abstract]   [Full Text] [Related]  

  • 42. Arkansas update. Study: do extra services increase compliance?
    Barnett S
    Fac Notes (New Orleans La); 1999; 11(1):11. PubMed ID: 11810885
    [No Abstract]   [Full Text] [Related]  

  • 43. Antiretroviral therapy: reference guide to major clinical trials in patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1995 May; 20(5):1145-51. PubMed ID: 7619990
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.
    Altice FL; Kamarulzaman A; Soriano VV; Schechter M; Friedland GH
    Lancet; 2010 Jul; 376(9738):367-87. PubMed ID: 20650518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
    Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):167-79. PubMed ID: 20375848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.
    Springer SA; Chen S; Altice F
    AIDS Care; 2009 Aug; 21(8):976-83. PubMed ID: 20024753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.
    Maru DS; Bruce RD; Walton M; Springer SA; Altice FL
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):176-81. PubMed ID: 19131891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.
    Maru DS; Kozal MJ; Bruce RD; Springer SA; Altice FL
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):555-63. PubMed ID: 18193497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.
    Maru DS; Bruce RD; Walton M; Mezger JA; Springer SA; Shield D; Altice FL
    AIDS Behav; 2008 Mar; 12(2):284-93. PubMed ID: 18085432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.
    Altice FL; Maru DS; Bruce RD; Springer SA; Friedland GH
    Clin Infect Dis; 2007 Sep; 45(6):770-8. PubMed ID: 17712763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach.
    Smith-Rohrberg D; Altice FL
    Clin Infect Dis; 2006 Nov; 43(9):1221-2; author reply 1222-3. PubMed ID: 17029149
    [No Abstract]   [Full Text] [Related]  

  • 52. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M; Viechtbauer W; Schaalma HP; Kok G; Abraham C; Hospers HJ
    Arch Intern Med; 2010 Feb; 170(3):240-50. PubMed ID: 20142568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adherence in clinical trials and in clinical practice.
    Walsh JC
    Antivir Ther; 1999; 4 Suppl 3():49-54. PubMed ID: 16021871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.
    Kirk O
    Dan Med Bull; 2004 Feb; 51(1):63-81. PubMed ID: 16009072
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.